Types of Psoriasis: Symptoms, Causes, and How to Tell Them Apart

<div class="smartlotion-article-content">

<div class="article-meta">
<span class="article-author">By Michael Anderson, Clinical Research Project Manager</span>
<span class="article-separator">•</span>
<time class="article-date" datetime="2025-01-15">Updated: January 15, 2025</time>
</div>

<div class="hero-content">
<p class="lead">Not all psoriasis looks the same. One person develops thick, scaly patches on their elbows. Another wakes up covered in tiny, drop-shaped spots after a sore throat. A third notices smooth, red skin hidden in their armpits. Psoriasis affects roughly 2 to 3% of the global population, yet many people go years without knowing which type they have.^{<a href="#ref1">[1]</a>}</p>

<p>If you have tried treatments that barely helped, the problem may not be the treatment itself. You might be managing the wrong type. Each form of psoriasis behaves differently, responds to different triggers, and often requires a different approach.^{<a href="#ref2">[2]</a>}</p>

<p>This guide walks you through every major type of psoriasis, explains why each one looks and acts the way it does, and helps you match your symptoms to the right category. For a broader look at psoriasis as a condition, see our complete <a href="https://harlanmd.com/blogs/smartlotion-blog/psoriasis">psoriasis overview</a>.</p>

<p>Recent research has mapped the distinct immune pathways behind each psoriasis type, revealing why a treatment that clears plaque psoriasis may do nothing for pustular disease.^{<a href="#ref3">[3]</a>} Understanding your type is the first step toward real relief.</p>
</div>

<div class="key-takeaways">
<h2>Key Takeaways</h2>
<ul class="takeaway-list">
<li>Plaque psoriasis accounts for about 80 to 90% of all psoriasis cases.^{<a href="#ref4">[4]</a>}</li>
<li>Guttate psoriasis often follows a streptococcal throat infection, especially in children.^{<a href="#ref5">[5]</a>}</li>
<li>Inverse psoriasis hides in skin folds and is frequently misdiagnosed as a fungal infection.^{<a href="#ref6">[6]</a>}^{<a href="#ref7">[7]</a>}</li>
<li>Generalized pustular psoriasis (von Zumbusch type) is a medical emergency requiring immediate hospital care.^{<a href="#ref8">[8]</a>}^{<a href="#ref9">[9]</a>}</li>
<li>Psoriasis can look very different on darker skin tones, leading to delayed diagnosis.^{<a href="#ref10">[10]</a>}^{<a href="#ref11">[11]</a>}</li>
<li>Literature estimates for psoriatic arthritis in psoriasis patients range from 7% to 40%; population-based studies suggest the clinically recognized rate is below 10%, and all patients should be screened regularly for joint symptoms.^{<a href="#ref12">[12]</a>}^{<a href="#ref13">[13]</a>}</li>
</ul>
</div>

<div class="table-of-contents">
<h2>Table of Contents</h2>
<nav role="navigation" aria-label="Table of contents">
<ol class="toc-list">
<li><a href="#what-is-psoriasis">What Is Psoriasis? Understanding the Autoimmune Basis</a>
<ol class="toc-sublist">
<li><a href="#why-psoriasis-takes-different-forms">Why Psoriasis Takes Different Forms</a></li>
</ol>
</li>
<li><a href="#plaque-psoriasis">Plaque Psoriasis: The Most Common Type</a>
<ol class="toc-sublist">
<li><a href="#plaque-across-skin-tones">Recognizing Plaque Psoriasis Across Skin Tones</a></li>
<li><a href="#plaque-common-locations">Common Locations and the Koebner Phenomenon</a></li>
</ol>
</li>
<li><a href="#guttate-psoriasis">Guttate Psoriasis: Small Spots, Big Impact</a>
<ol class="toc-sublist">
<li><a href="#strep-throat-connection">The Strep Throat Connection</a></li>
<li><a href="#will-guttate-go-away">Will Guttate Psoriasis Go Away?</a></li>
</ol>
</li>
<li><a href="#inverse-psoriasis">Inverse Psoriasis: Hidden in Skin Folds</a>
<ol class="toc-sublist">
<li><a href="#why-inverse-looks-different">Why Inverse Psoriasis Looks Different</a></li>
</ol>
</li>
<li><a href="#pustular-psoriasis">Pustular Psoriasis: When Inflammation Intensifies</a>
<ol class="toc-sublist">
<li><a href="#localized-vs-generalized-pustular">Localized vs. Generalized Pustular Psoriasis</a></li>
<li><a href="#pustular-emergency">When Pustular Psoriasis Becomes an Emergency</a></li>
</ol>
</li>
<li><a href="#erythrodermic-psoriasis">Erythrodermic Psoriasis: The Rarest and Most Severe Form</a>
<ol class="toc-sublist">
<li><a href="#erythrodermic-warning-signs">Recognizing the Warning Signs</a></li>
</ol>
</li>
<li><a href="#psoriasis-by-location">Psoriasis by Location: Scalp, Nails, and Joints</a>
<ol class="toc-sublist">
<li><a href="#scalp-psoriasis">Scalp Psoriasis</a></li>
<li><a href="#nail-psoriasis">Nail Psoriasis</a></li>
<li><a href="#psoriatic-arthritis">Psoriatic Arthritis</a></li>
</ol>
</li>
<li><a href="#comparing-all-types">Comparing All Types of Psoriasis at a Glance</a>
<ol class="toc-sublist">
<li><a href="#more-than-one-type">Can You Have More Than One Type?</a></li>
<li><a href="#psoriasis-different-skin-tones">How Psoriasis Looks on Different Skin Tones</a></li>
</ol>
</li>
<li><a href="#treatment-approaches">Treatment Approaches by Psoriasis Type</a>
<ol class="toc-sublist">
<li><a href="#topical-light-therapies">Topical and Light-Based Therapies</a></li>
<li><a href="#systemic-biologic-options">Systemic and Biologic Options</a></li>
<li><a href="#matching-treatment-to-type">Matching Treatment to Your Type</a></li>
</ol>
</li>
<li><a href="#when-to-see-dermatologist">When to See a Dermatologist</a></li>
<li><a href="#faq-types-of-psoriasis">Frequently Asked Questions About Types of Psoriasis</a></li>
</ol>
</nav>
</div>

<h2 class="section-heading" id="what-is-psoriasis">What Is Psoriasis? Understanding the Autoimmune Basis</h2>

<p><strong>Psoriasis</strong> is a chronic, immune-mediated inflammatory disease that speeds up the life cycle of skin cells. In healthy skin, new cells grow and rise to the surface over about 28 to 30 days. In psoriatic skin, that process compresses to just 3 to 4 days.^{<a href="#ref14">[14]</a>} The result: cells pile up on the surface faster than the body can shed them, forming the raised, scaly patches most people associate with the disease.</p>

<p>Psoriasis is not just a skin problem. It is a systemic condition driven by an overactive immune system. For a full overview of how this systemic inflammation develops and is managed, see our <a href="https://harlanmd.com/blogs/smartlotion-blog/psoriasis">psoriasis symptoms, causes, and treatment guide</a>. Genetic studies estimate heritability at roughly 60 to 90%, with over 80 susceptibility loci identified so far.^{<a href="#ref15">[15]</a>} Environmental triggers, including stress, infections, and certain medications, activate these genetic predispositions and set the inflammatory cascade in motion.^{<a href="#ref16">[16]</a>}</p>

<p>At the core of that cascade sit two key immune pathways: the Th1 and Th17 axes. These pathways produce inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-17 (IL-17), and interleukin-23 (IL-23). Together, they drive the rapid skin cell turnover seen in psoriasis.^{<a href="#ref17">[17]</a>} Psoriasis is also associated with increased risk of cardiovascular disease, metabolic syndrome, inflammatory bowel disease, and depression, reflecting its systemic inflammatory nature.^{<a href="#ref18">[18]</a>} Understanding these connections is part of why psoriasis is treated as a whole-body condition rather than a skin-only problem — a distinction explored further in our <a href="https://harlanmd.com/blogs/smartlotion-blog/psoriasis">complete psoriasis guide</a>.</p>

<!-- [IMAGE PLACEMENT: Immune pathway divergence diagram showing how different immune pathways lead to different psoriasis types] -->
<img src="https://cdn.shopify.com/s/files/1/0529/7170/0417/files/psoriasis-types-immune-pathway-process-01.webp?v=1775676734" alt="Diagram showing how different immune pathways in psoriasis lead to different clinical types including plaque, guttate, and pustular psoriasis" class="content-image" width="1200" height="800">

<h3 class="subsection-heading" id="why-psoriasis-takes-different-forms">Why Psoriasis Takes Different Forms</h3>

<p>Here is what most guides skip: the reason psoriasis takes different forms comes down to which immune cells dominate the response.</p>

<ul class="bulleted-list">
<li><strong>T-cell dominant responses</strong> drive plaque and guttate psoriasis, producing the classic raised, scaly lesions.^{<a href="#ref17">[17]</a>}</li>
<li><strong>Neutrophil-dominant responses</strong> characterize pustular psoriasis, where white blood cells flood the skin and form sterile blisters.^{<a href="#ref8">[8]</a>}</li>
<li><strong>Widespread, uncontrolled inflammation</strong> produces erythrodermic psoriasis, the rarest and most dangerous form.^{<a href="#ref19">[19]</a>}</li>
</ul>

<p>Understanding which pathway drives your type helps explain why treatments that work for one person may fail for another. The sections below break down each type so you can recognize the differences.</p>

<div class="featured-resource">
<h4>📚 Related Resource</h4>
<p>See our guide: <a href="https://harlanmd.com/blogs/smartlotion-blog/psoriasis">Psoriasis: A Complete Guide to Causes, Types, and Treatment</a></p>
</div>

<h2 class="section-heading" id="plaque-psoriasis">Plaque Psoriasis: The Most Common Type</h2>

<p>Plaque psoriasis accounts for approximately 80 to 90% of all psoriasis cases, making it by far the most common type.^{<a href="#ref4">[4]</a>} If you are unsure whether your skin condition is plaque psoriasis or another inflammatory condition, our guide on the <a href="https://harlanmd.com/blogs/smartlotion-blog/difference-between-psoriasis-and-eczema">difference between psoriasis and eczema</a> can help you distinguish the two. You will recognize it by its hallmark features: raised, well-defined patches (called plaques) covered with silvery-white scale. These plaques can range from a few centimeters to large areas covering significant portions of the body.^{<a href="#ref4">[4]</a>}</p>

<p>The plaques form because skin cells accumulate 10 times faster than normal.^{<a href="#ref14">[14]</a>} Beneath the visible scale, the skin is inflamed and red. Scratching or removing the scale can reveal tiny pinpoint bleeding spots, a clinical sign known as the <em>Auspitz sign</em>.^{<a href="#ref20">[20]</a>}</p>

<h3 class="subsection-heading" id="plaque-across-skin-tones">Recognizing Plaque Psoriasis Across Skin Tones</h3>

<p>Most medical resources describe plaque psoriasis as "red with silvery scale." That description fits lighter skin tones. On darker skin, the picture changes significantly.</p>

<ul class="bulleted-list">
<li><strong>Lighter skin:</strong> Plaques appear salmon-pink to red with prominent silvery-white scale.^{<a href="#ref4">[4]</a>}</li>
<li><strong>Medium skin tones:</strong> Plaques may look darker red or dusky pink, with scale that appears more yellowish.</li>
<li><strong>Darker skin:</strong> Plaques often appear violaceous (purple-toned) or dark brown, with thicker scale and more prominent post-inflammatory hyperpigmentation after the plaque clears.^{<a href="#ref10">[10]</a>}</li>
</ul>

<!-- [IMAGE PLACEMENT: Comparison of plaque psoriasis appearance across skin tones] -->
<img src="https://cdn.shopify.com/s/files/1/0529/7170/0417/files/psoriasis-types-skin-tone-comparison-01.webp?v=1775676740" alt="Comparison chart showing how plaque psoriasis appears differently on lighter, medium, and darker skin tones" class="content-image" width="1200" height="800">

<p class="key-insight"><strong>Psoriasis on darker skin is underdiagnosed partly because clinicians rely on "redness" as a key feature, which may not be visible on melanin-rich skin.</strong>^{<a href="#ref10">[10]</a>}</p>

<h3 class="subsection-heading" id="plaque-common-locations">Common Locations and the Koebner Phenomenon</h3>

<p>Plaque psoriasis favors certain body sites: the elbows, knees, lower back (sacral area), and scalp. Scalp involvement affects roughly 50% of people with plaque psoriasis and can range from mild flaking to thick, crusted plaques extending beyond the hairline.^{<a href="#ref21">[21]</a>} For guidance on whether to adjust your hairstyle to improve treatment access, see our article on <a href="https://harlanmd.com/blogs/smartlotion-blog/should-i-cut-my-hair-if-i-have-psoriasis">whether to cut your hair if you have psoriasis</a>.</p>

<p>One feature that surprises many patients is the <em>Koebner phenomenon</em>: new plaques forming at sites of skin injury. A cut, scrape, sunburn, or even a tattoo can trigger a new plaque at the exact location of the trauma, typically within 10 to 20 days.^{<a href="#ref22">[22]</a>} If you notice psoriasis appearing where you recently injured your skin, this is likely why.</p>

<div class="clinical-callout">
<h4>When to worry about plaque psoriasis:</h4>
<ul>
<li><strong>Spreading rapidly:</strong> Plaques covering more than 10% of your body surface area are classified as moderate-to-severe and may need systemic treatment.^{<a href="#ref23">[23]</a>}</li>
<li><strong>Joint pain:</strong> Stiffness or swelling alongside skin plaques could signal psoriatic arthritis.^{<a href="#ref12">[12]</a>}</li>
<li><strong>Scalp involvement:</strong> Thick scalp plaques can cause temporary hair thinning.^{<a href="#ref24">[24]</a>} See our guide on <a href="https://harlanmd.com/blogs/smartlotion-blog/should-i-cut-my-hair-if-i-have-psoriasis">managing hair with scalp psoriasis</a>.</li>
</ul>
</div>

<h2 class="section-heading" id="guttate-psoriasis">Guttate Psoriasis: Small Spots, Big Impact</h2>

<p>Guttate psoriasis is the second most common type, affecting roughly 8 to 10% of people with psoriasis.^{<a href="#ref25">[25]</a>} For a full clinical breakdown of this type, see our dedicated <a href="https://harlanmd.com/blogs/smartlotion-blog/guttate-psoriasis-what-it-is-and-how-to-manage-it">guttate psoriasis treatment guide</a>. The name comes from the Latin word <em>gutta</em>, meaning "drop." That is exactly what the lesions look like: small, drop-shaped papules scattered across the trunk, arms, and legs.</p>

<p>Unlike the thick, well-defined plaques of plaque psoriasis, guttate lesions are typically less than 1 centimeter in diameter. They appear suddenly, often covering large areas of skin within days. The onset can feel alarming, especially for children and young adults who make up the majority of guttate psoriasis cases.^{<a href="#ref25">[25]</a>}</p>

<h3 class="subsection-heading" id="strep-throat-connection">The Strep Throat Connection</h3>

<p>The strongest trigger for guttate psoriasis is a streptococcal throat infection. Studies show that up to two-thirds of guttate psoriasis flares follow a strep throat episode by 2 to 3 weeks.^{<a href="#ref5">[5]</a>} The connection lies in molecular mimicry: streptococcal M-proteins share structural similarities with proteins in the skin, causing the immune system to attack skin cells after fighting the infection.^{<a href="#ref26">[26]</a>}</p>

<p>Other triggers include upper respiratory infections, stress, and certain medications. But strep remains the most well-documented cause, which is why your dermatologist may order a throat culture or strep antibody test if guttate psoriasis appears suddenly.</p>

<h3 class="subsection-heading" id="will-guttate-go-away">Will Guttate Psoriasis Go Away?</h3>

<p>This is the question most patients ask first. The answer depends on your history.</p>

<ul class="bulleted-list">
<li><strong>First episode with clear strep trigger:</strong> About one-third of cases resolve completely within a few months without progressing to chronic psoriasis.^{<a href="#ref27">[27]</a>}</li>
<li><strong>Recurrent episodes:</strong> Some patients experience repeated flares with each new infection.</li>
<li><strong>Transition to plaque psoriasis:</strong> Roughly one-third of guttate psoriasis cases eventually develop into chronic plaque psoriasis over time.^{<a href="#ref27">[27]</a>}</li>
</ul>

<div class="featured-resource">
<h4>📚 Related Resource</h4>
<p>See our guide: <a href="https://harlanmd.com/blogs/smartlotion-blog/guttate-psoriasis-what-it-is-and-how-to-manage-it">Guttate Psoriasis: What It Is and How to Manage It</a></p>
</div>

<p>For detailed treatment protocols, visit our <a href="https://help.harlanmd.com/article/979biy5bj0-guttate">guttate psoriasis treatment guide</a>.</p>

<h2 class="section-heading" id="inverse-psoriasis">Inverse Psoriasis: Hidden in Skin Folds</h2>

<p>Inverse psoriasis (also called flexural psoriasis or intertriginous psoriasis) hides where skin touches skin. You will find it in the armpits, groin, under the breasts, between the buttocks, and behind the knees. It affects an estimated 3 to 7% of psoriasis patients as an isolated finding, though it co-occurs with plaque psoriasis in up to 25 to 30% of cases.^{<a href="#ref6">[6]</a>} Teenagers with flexural involvement can find age-specific guidance in our <a href="https://help.harlanmd.com/article/qxs55i6c1o-flexure-rash-intertrigo-or-flexure-psoriasis-teenagers">flexure psoriasis protocol for teenagers</a>.</p>

<p>The frustration of inverse psoriasis goes beyond the physical. Because it occurs in sensitive, private areas, many people delay seeking help. The constant friction and moisture in skin folds make it particularly uncomfortable.</p>

<h3 class="subsection-heading" id="why-inverse-looks-different">Why Inverse Psoriasis Looks Different</h3>

<p>Inverse psoriasis breaks the visual rules you might expect. Instead of thick, scaly plaques, you see smooth, shiny, deep-red patches. The reason: moisture in skin folds prevents the characteristic scale from forming.^{<a href="#ref28">[28]</a>}</p>

<p>This smooth appearance creates a diagnostic problem. Inverse psoriasis is frequently misdiagnosed as a fungal infection (candidiasis or tinea), contact dermatitis, or bacterial infection.^{<a href="#ref7">[7]</a>} The treatments for these conditions differ significantly, so an incorrect diagnosis means wasted time and continued suffering.</p>

<div class="emphasis-box">
<h4>⚠️ Commonly Confused:</h4>
<p>Inverse psoriasis and fungal infections can look nearly identical in skin folds. If antifungal treatments are not working, ask your dermatologist to reconsider the diagnosis. A skin biopsy can confirm psoriasis.^{<a href="#ref7">[7]</a>}</p>
</div>

<p>Friction and sweating worsen inverse psoriasis. Wearing loose, breathable clothing and keeping skin folds dry can reduce irritation. For more on managing flexural skin conditions, see our <a href="https://help.harlanmd.com/article/h4v8gzmqlq-flexure-rash-intertrigo-or-flexure-psoriasis">flexure rash and intertrigo guide</a>.</p>

<h2 class="section-heading" id="pustular-psoriasis">Pustular Psoriasis: When Inflammation Intensifies</h2>

<p>Pustular psoriasis looks alarming. White, pus-filled blisters (pustules) appear on the skin, surrounded by red, inflamed tissue. But here is the critical point: these pustules are sterile. They contain white blood cells (neutrophils), not bacteria. Pustular psoriasis is not an infection and is not contagious.^{<a href="#ref9">[9]</a>}</p>

<p>The immune mechanism behind pustular psoriasis differs from plaque psoriasis. While plaque disease is driven primarily by the IL-23/IL-17 axis, pustular psoriasis involves the IL-36 pathway. Mutations in the IL-36 receptor antagonist gene (IL36RN) have been identified in many patients with generalized pustular psoriasis.^{<a href="#ref8">[8]</a>}</p>

<!-- [IMAGE PLACEMENT: Comparison of localized vs generalized pustular psoriasis] -->
<img src="https://cdn.shopify.com/s/files/1/0529/7170/0417/files/psoriasis-types-pustular-comparison-01.webp?v=1775676739" alt="Comparison chart showing differences between localized palmoplantar pustulosis and generalized von Zumbusch pustular psoriasis" class="content-image" width="1200" height="800">

<h3 class="subsection-heading" id="localized-vs-generalized-pustular">Localized vs. Generalized Pustular Psoriasis</h3>

<p>Pustular psoriasis comes in two main forms, and the distinction matters enormously.</p>

<div class="table-wrapper">
<table class="data-table">
<thead>
<tr><th>Feature</th><th>Localized (Palmoplantar Pustulosis)</th><th>Generalized (Von Zumbusch)</th></tr>
</thead>
<tbody>
<tr><td><strong>Location</strong></td><td>Palms and soles only</td><td>Widespread across the body</td></tr>
<tr><td><strong>Onset</strong></td><td>Gradual, chronic course</td><td>Sudden, acute onset</td></tr>
<tr><td><strong>Severity</strong></td><td>Painful but not life-threatening</td><td>Medical emergency</td></tr>
<tr><td><strong>Systemic symptoms</strong></td><td>None typically</td><td>Fever, chills, rapid pulse, fatigue</td></tr>
<tr><td><strong>Hospitalization</strong></td><td>Rarely needed</td><td>Often required</td></tr>
</tbody>
</table>
</div>

<p>Palmoplantar pustulosis (PPP) is the more common localized form.^{<a href="#ref29">[29]</a>} It causes recurring crops of pustules on the hands and feet that dry into brown, scaly patches.^{<a href="#ref29">[29]</a>} PPP can be severely disabling, making it painful to walk or use your hands.^{<a href="#ref29">[29]</a>}</p>

<p>Certain medications have historically been associated with pustular psoriasis flares, including lithium and certain antimalarials. Systemic corticosteroid withdrawal has long been cited as a trigger, though recent evidence suggests this risk may be lower than traditionally taught — a large cohort study found no pustular flares among nearly 2,000 psoriasis patients who received systemic corticosteroids.^{<a href="#ref30">[30]</a>} Never stop systemic psoriasis medications abruptly without medical guidance, and discuss any corticosteroid use with your dermatologist.</p>

<h3 class="subsection-heading" id="pustular-emergency">When Pustular Psoriasis Becomes an Emergency</h3>

<div class="emphasis-box">
<h4>⚠️ Medical Emergency:</h4>
<p>Generalized pustular psoriasis (von Zumbusch type) can be life-threatening.^{<a href="#ref8">[8]</a>}^{<a href="#ref31">[31]</a>} If you develop widespread pustules with fever, chills, or rapid heart rate, seek emergency medical care immediately. This form can cause dehydration, secondary infection, and organ failure if untreated.</p>
</div>

<p>The good news: targeted therapies are now available. Spesolimab, an IL-36 receptor antibody, received FDA approval in 2022 specifically for generalized pustular psoriasis flares.^{<a href="#ref31">[31]</a>} It was the first treatment designed for this exact immune pathway.</p>

<h2 class="section-heading" id="erythrodermic-psoriasis">Erythrodermic Psoriasis: The Rarest and Most Severe Form</h2>

<p>Erythrodermic psoriasis affects roughly 1 to 2.25% of people with psoriasis, making it the rarest major type.^{<a href="#ref19">[19]</a>} It is also the most dangerous. The entire body surface becomes inflamed, turning a fiery red. Skin sheds in large sheets rather than small flakes.</p>

<p>This widespread inflammation disrupts the skin's ability to perform its most basic functions. Your skin can no longer regulate body temperature properly, maintain fluid balance, or serve as an effective barrier against infection.^{<a href="#ref19">[19]</a>} The result can be hypothermia, severe dehydration, and sepsis.</p>

<h3 class="subsection-heading" id="erythrodermic-warning-signs">Recognizing the Warning Signs</h3>

<p>Erythrodermic psoriasis can develop from any other type of psoriasis. It typically arises in the setting of poorly controlled or destabilized psoriasis, and clinicians should be alert to any rapid, widespread worsening of existing disease.^{<a href="#ref19">[19]</a>}</p>

<div class="emphasis-box">
<h4>⚠️ EMERGENCY: Call 911 or Go to the ER</h4>
<p>If you develop widespread redness covering most of your body with skin shedding in sheets, fever, or chills, seek emergency care immediately. Erythrodermic psoriasis requires hospitalization for fluid management, temperature regulation, and infection prevention.^{<a href="#ref19">[19]</a>}</p>
</div>

<p>Erythrodermic psoriasis carries a significant mortality risk if untreated, particularly in older adults and those with cardiovascular comorbidities.^{<a href="#ref32">[32]</a>} Early recognition saves lives.</p>

<h2 class="section-heading" id="psoriasis-by-location">Psoriasis by Location: Scalp, Nails, and Joints</h2>

<p>Some forms of psoriasis are defined not by their immune mechanism but by where they appear on the body. Scalp psoriasis, nail psoriasis, and psoriatic arthritis are sometimes listed as separate "types," but they are better understood as psoriasis affecting specific body sites. Each comes with unique challenges.</p>

<!-- [IMAGE PLACEMENT: Data visualization showing prevalence of psoriasis by body location] -->
<img src="https://cdn.shopify.com/s/files/1/0529/7170/0417/files/psoriasis-types-location-prevalence-01.webp?v=1775676736" alt="Data visualization showing psoriasis prevalence by body location: scalp affects about 50%, nails about 50%, and joints about 30% of psoriasis patients" class="content-image" width="1200" height="800">

<h3 class="subsection-heading" id="scalp-psoriasis">Scalp Psoriasis</h3>

<p>Scalp psoriasis affects approximately 45 to 56% of people with psoriasis, making it one of the most common locations.^{<a href="#ref21">[21]</a>} It ranges from mild flaking that resembles dandruff to thick, crusted plaques covering the entire scalp.</p>

<p>What makes scalp psoriasis particularly frustrating is its visibility. Plaques can extend beyond the hairline onto the forehead, behind the ears, and down the nape of the neck. Thick scale can trap hair, and aggressive scratching or removal of scale can cause temporary hair loss (though the hair typically regrows once the psoriasis is controlled).^{<a href="#ref24">[24]</a>}</p>

<p>For practical tips on managing your hair with scalp psoriasis, see our <a href="https://help.harlanmd.com/article/t22m1gggh3-scalp-psoriasis">scalp psoriasis treatment protocol</a>.</p>

<h3 class="subsection-heading" id="nail-psoriasis">Nail Psoriasis</h3>

<p>Nail psoriasis affects roughly 50% of people with skin psoriasis and up to 80% of those with psoriatic arthritis.^{<a href="#ref33">[33]</a>} It can affect fingernails, toenails, or both. Common signs include:</p>

<ul class="bulleted-list">
<li><strong>Pitting:</strong> Small dents or depressions in the nail surface^{<a href="#ref33">[33]</a>}</li>
<li><strong>Onycholysis:</strong> The nail separates from the nail bed, starting at the tip</li>
<li><strong>Subungual hyperkeratosis:</strong> Chalky buildup under the nail</li>
<li><strong>Oil-drop discoloration:</strong> Yellowish-brown spots visible through the nail plate</li>
</ul>

<p class="key-insight"><strong>Nail changes can predict psoriatic arthritis.</strong> Studies show that nail involvement is a strong independent risk factor for developing joint disease.^{<a href="#ref34">[34]</a>}</p>

<p>Nail psoriasis is often confused with fungal nail infections (onychomycosis). This diagnostic challenge is similar to the confusion between psoriasis and other inflammatory skin conditions — our guide on <a href="https://harlanmd.com/blogs/smartlotion-blog/types-of-skin-rashes-seen-in-adults">identifying common skin rashes in adults</a> provides a broader differential framework. The two conditions can even coexist. A nail clipping sent for fungal culture or a dermatoscopic exam can help distinguish them.^{<a href="#ref35">[35]</a>}</p>

<h3 class="subsection-heading" id="psoriatic-arthritis">Psoriatic Arthritis</h3>

<p>Psoriatic arthritis (PsA) develops in a meaningful proportion of people with psoriasis — estimates in the literature range from 7% to 40%, with population-based studies suggesting clinically recognized rates below 10% over a lifetime, while cross-sectional screening studies report higher figures. Early screening using validated tools can help catch joint disease before irreversible damage occurs; learn more in our <a href="https://harlanmd.com/blogs/smartlotion-blog/psoriasis">complete psoriasis guide</a>.^{<a href="#ref12">[12]</a>}^{<a href="#ref13">[13]</a>} It causes joint pain, stiffness, and swelling that can affect any joint in the body. In most cases, skin symptoms appear years before joint symptoms, but about 15% of patients develop arthritis first.^{<a href="#ref36">[36]</a>}</p>

<p>The stakes with psoriatic arthritis are high. Without treatment, PsA can cause irreversible joint damage and disability. Early diagnosis and treatment with disease-modifying agents can slow or prevent this progression.^{<a href="#ref37">[37]</a>} Patients with psoriatic arthritis often benefit from a <a href="https://help.harlanmd.com/article/rheay0y4pt-psoriasis">comprehensive psoriasis management protocol</a> that addresses both skin and joint symptoms.</p>

<div class="table-wrapper">
<table class="data-table">
<thead>
<tr><th>Feature</th><th>Scalp Psoriasis</th><th>Nail Psoriasis</th><th>Psoriatic Arthritis</th></tr>
</thead>
<tbody>
<tr><td><strong>Prevalence in psoriasis patients</strong></td><td>45–56%^{<a href="#ref21">[21]</a>}</td><td>~50%^{<a href="#ref33">[33]</a>}</td><td>7–40% (varies by study)^{<a href="#ref12">[12]</a>}^{<a href="#ref13">[13]</a>}</td></tr>
<tr><td><strong>Key symptoms</strong></td><td>Flaking, thick plaques, itching</td><td>Pitting, onycholysis, discoloration</td><td>Joint pain, stiffness, swelling</td></tr>
<tr><td><strong>When to worry</strong></td><td>Extends beyond hairline, hair loss</td><td>Multiple nails affected, joint pain</td><td>Morning stiffness lasting 30+ minutes</td></tr>
</tbody>
</table>
</div>

<h2 class="section-heading" id="comparing-all-types">Comparing All Types of Psoriasis at a Glance</h2>

<p>With so many types, keeping them straight can feel overwhelming. The table below puts all major types of psoriasis side by side so you can compare their key features at a glance.</p>

<!-- [IMAGE PLACEMENT: Master comparison infographic of all psoriasis types] -->
<img src="https://cdn.shopify.com/s/files/1/0529/7170/0417/files/psoriasis-types-master-comparison-01.webp?v=1775676737" alt="Infographic comparing all major types of psoriasis including prevalence, appearance, common locations, key triggers, and severity range" class="content-image" width="1200" height="1000">

<div class="table-wrapper">
<table class="data-table">
<thead>
<tr><th>Type</th><th>Prevalence</th><th>Appearance</th><th>Common Locations</th><th>Key Triggers</th><th>Severity</th></tr>
</thead>
<tbody>
<tr><td><strong>Plaque</strong></td><td>80–90%^{<a href="#ref4">[4]</a>}</td><td>Raised plaques, silvery scale</td><td>Elbows, knees, scalp, lower back</td><td>Stress, injury, infection</td><td>Mild to severe</td></tr>
<tr><td><strong>Guttate</strong></td><td>8–10%^{<a href="#ref25">[25]</a>}</td><td>Small, drop-shaped spots</td><td>Trunk, arms, legs</td><td>Strep throat, URI</td><td>Mild to moderate</td></tr>
<tr><td><strong>Inverse</strong></td><td>3–7%^{<a href="#ref6">[6]</a>}</td><td>Smooth, shiny, red patches</td><td>Skin folds (armpits, groin)</td><td>Friction, sweating</td><td>Mild to moderate</td></tr>
<tr><td><strong>Pustular</strong></td><td>~3%^{<a href="#ref9">[9]</a>}</td><td>White, pus-filled blisters</td><td>Hands/feet (localized) or widespread</td><td>Drug withdrawal, infection</td><td>Moderate to life-threatening</td></tr>
<tr><td><strong>Erythrodermic</strong></td><td>1–2.25%^{<a href="#ref19">[19]</a>}</td><td>Widespread fiery redness, skin shedding</td><td>Entire body</td><td>Treatment withdrawal, sunburn</td><td>Life-threatening</td></tr>
</tbody>
</table>
</div>

<h3 class="subsection-heading" id="more-than-one-type">Can You Have More Than One Type?</h3>

<p>Yes. Many people experience more than one type of psoriasis during their lifetime. Plaque psoriasis can coexist with inverse psoriasis in the same patient. Guttate psoriasis can transition into chronic plaque disease. And any type can potentially progress to erythrodermic psoriasis under certain conditions.</p>

<p>This overlap is one reason accurate diagnosis matters so much. Your treatment plan should address all active types, not just the most visible one.</p>

<h3 class="subsection-heading" id="psoriasis-different-skin-tones">How Psoriasis Looks on Different Skin Tones</h3>

<p>Psoriasis research and medical education have historically focused on lighter skin. This creates real diagnostic gaps for people with darker skin tones. Studies show that psoriasis in Black patients is more likely to be misdiagnosed or diagnosed later.^{<a href="#ref11">[11]</a>} The classic "red" description does not match what clinicians see on melanin-rich skin, creating a diagnostic gap.</p>

<ul class="bulleted-list">
<li><strong>Scale appearance:</strong> Scale may appear more silvery-white on darker skin, creating higher contrast with the surrounding skin.</li>
<li><strong>Post-inflammatory changes:</strong> Darker skin is more prone to post-inflammatory hyperpigmentation or hypopigmentation after psoriasis clears, which can persist for months.^{<a href="#ref10">[10]</a>}</li>
<li><strong>Severity assessment:</strong> Standard severity tools like the PASI score rely on erythema (redness), which is harder to assess on darker skin, potentially leading to underestimation of disease severity.^{<a href="#ref11">[11]</a>}</li>
</ul>

<p>If you have darker skin and suspect psoriasis, seek a dermatologist experienced in treating diverse skin tones. Accurate diagnosis is the foundation of effective treatment. To understand how psoriasis differs from similar-looking conditions, see our guide on the <a href="https://harlanmd.com/blogs/smartlotion-blog/difference-between-psoriasis-and-eczema">difference between psoriasis and eczema</a>.</p>

<h2 class="section-heading" id="treatment-approaches">Treatment Approaches by Psoriasis Type</h2>

<p>No single treatment works for every type of psoriasis. The right approach depends on your specific type, severity, affected body areas, and overall health. Here is how the treatment landscape maps to each type.</p>

<h3 class="subsection-heading" id="topical-light-therapies">Topical and Light-Based Therapies</h3>

<p>Topical treatments remain the first line for mild-to-moderate psoriasis across most types. The most commonly prescribed options include:</p>

<ul class="bulleted-list">
<li><strong>Topical corticosteroids:</strong> The mainstay of psoriasis treatment, available in varying potencies. Low-potency formulations work for sensitive areas like the face and skin folds. Higher potencies target thick plaques on the body.^{<a href="#ref38">[38]</a>}</li>
<li><strong>Vitamin D analogues (calcipotriol):</strong> Slow skin cell growth and reduce scaling. Often combined with corticosteroids for better results.^{<a href="#ref39">[39]</a>}</li>
<li><strong>Coal tar:</strong> One of the oldest psoriasis treatments, still effective for reducing scaling, itching, and inflammation.^{<a href="#ref40">[40]</a>}</li>
<li><strong>Calcineurin inhibitors:</strong> Useful for inverse psoriasis and facial psoriasis where strong steroids carry higher risk of side effects.^{<a href="#ref38">[38]</a>}</li>
</ul>

<p>Phototherapy (light therapy) uses controlled doses of ultraviolet light to slow skin cell turnover. Narrowband UVB phototherapy is effective for widespread plaque and guttate psoriasis, with studies showing clearance or near-clearance in approximately 60 to 70% of patients.^{<a href="#ref41">[41]</a>} For patients managing scalp involvement alongside body psoriasis, our guide on <a href="https://harlanmd.com/blogs/smartlotion-blog/should-i-cut-my-hair-if-i-have-psoriasis">hair care with scalp psoriasis</a> addresses practical treatment access considerations.</p>

<p>For mild-to-moderate psoriasis, over-the-counter options can also play a role. <a href="https://harlanmd.com/">SmartLotion</a> is a prebiotic anti-inflammatory <a href="https://harlanmd.com/">psoriasis treatment cream</a> that combines a low-dose corticosteroid with sulfur and probiotics to address inflammation while supporting the skin's microbiome. Learn more about sulfur's role in psoriasis management in our guide on <a href="https://harlanmd.com/blogs/smartlotion-blog/sulfur-a-timeless-treatment-for-acne-eczema-and-psoriasis">sulfur as a treatment for psoriasis</a>.</p>

<h3 class="subsection-heading" id="systemic-biologic-options">Systemic and Biologic Options</h3>

<p>When topical treatments and phototherapy are not enough, systemic therapies target the immune system from within.</p>

<ul class="bulleted-list">
<li><strong>Methotrexate:</strong> A traditional systemic agent effective for moderate-to-severe plaque psoriasis and psoriatic arthritis.^{<a href="#ref42">[42]</a>}</li>
<li><strong>Cyclosporine:</strong> A fast-acting immunosuppressant used for short-term control of severe flares, including erythrodermic psoriasis.^{<a href="#ref42">[42]</a>}</li>
<li><strong>Biologic therapies:</strong> Targeted treatments that block specific immune molecules. TNF-alpha inhibitors (adalimumab, etanercept), IL-17 inhibitors (secukinumab, ixekizumab), and IL-23 inhibitors (guselkumab, risankizumab) have transformed outcomes for moderate-to-severe plaque psoriasis and psoriatic arthritis.^{<a href="#ref42">[42]</a>}</li>
<li><strong>Spesolimab:</strong> The first IL-36 receptor antibody, approved specifically for generalized pustular psoriasis flares.^{<a href="#ref31">[31]</a>}</li>
</ul>

<p>IL-17 inhibitors have shown PASI 90 response rates (90% or greater improvement) in approximately 60 to 70% of patients with moderate-to-severe plaque psoriasis in clinical trials.^{<a href="#ref42">[42]</a>}</p>

<!-- [IMAGE PLACEMENT: Treatment-to-type mapping matrix] -->
<img src="https://cdn.shopify.com/s/files/1/0529/7170/0417/files/psoriasis-types-treatment-matrix-01.webp?v=1775676742" alt="Comparison chart mapping psoriasis treatment options to psoriasis types showing which treatments apply to plaque, guttate, inverse, pustular, and erythrodermic psoriasis" class="content-image" width="1200" height="900">

<h3 class="subsection-heading" id="matching-treatment-to-type">Matching Treatment to Your Type</h3>

<p>The most important takeaway from this section: treatment must match your type.</p>

<div class="clinical-callout">
<h4>Treatment matching by type:</h4>
<ul>
<li><strong>Plaque psoriasis:</strong> Full treatment ladder available, from topicals to biologics depending on severity.^{<a href="#ref38">[38]</a>}</li>
<li><strong>Guttate psoriasis:</strong> Phototherapy is particularly effective. Antibiotics may help if strep is the trigger.^{<a href="#ref5">[5]</a>}</li>
<li><strong>Inverse psoriasis:</strong> Low-potency topical steroids or calcineurin inhibitors. Avoid strong steroids in skin folds.^{<a href="#ref28">[28]</a>}</li>
<li><strong>Pustular psoriasis:</strong> Spesolimab for generalized flares. Acitretin or methotrexate for chronic management.^{<a href="#ref31">[31]</a>}</li>
<li><strong>Erythrodermic psoriasis:</strong> Hospitalization, cyclosporine for rapid control, then transition to maintenance therapy.^{<a href="#ref19">[19]</a>}</li>
</ul>
</div>

<p>For a detailed treatment protocol tailored to your psoriasis type, visit our <a href="https://help.harlanmd.com/article/rheay0y4pt-psoriasis">psoriasis treatment guide</a>.</p>

<h2 class="section-heading" id="when-to-see-dermatologist">When to See a Dermatologist</h2>

<p>Some situations call for urgent medical attention. Others simply need a scheduled appointment. Knowing the difference can protect your health.</p>

<div class="action-steps">
<p><strong>If you do only one thing:</strong> See a dermatologist if your current treatment stops working or your psoriasis changes in appearance.</p>
<ul class="numbered-list">
<li><strong>Seek emergency care if:</strong> You develop widespread redness with skin shedding (erythrodermic psoriasis), widespread pustules with fever (generalized pustular psoriasis), or sudden severe joint swelling.^{<a href="#ref19">[19]</a>}</li>
<li><strong>Schedule an appointment if:</strong> Your psoriasis is spreading despite treatment, you notice new nail changes, you develop joint stiffness or pain, or your current type seems to be changing.</li>
<li><strong>Request a second opinion if:</strong> You have been diagnosed with a fungal infection in skin folds or nails that is not responding to antifungal treatment. It may be inverse or nail psoriasis instead.^{<a href="#ref7">[7]</a>}^{<a href="#ref35">[35]</a>}</li>
</ul>
</div>

<p>Accurate diagnosis is the foundation of effective treatment. Psoriasis can mimic other conditions, and other conditions can mimic psoriasis. A board-certified dermatologist can distinguish between them and build a treatment plan matched to your specific type. For a broader look at skin conditions that can resemble psoriasis, see our guide on <a href="https://harlanmd.com/blogs/smartlotion-blog/types-of-skin-rashes-seen-in-adults">types of skin rashes in adults</a>.</p>

<h2 class="section-heading" id="faq-types-of-psoriasis">Frequently Asked Questions About Types of Psoriasis</h2>

<h3 class="subsection-heading" id="faq-seven-types">What are the 7 types of psoriasis?</h3>

<p>The major types of psoriasis include plaque psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, and erythrodermic psoriasis. Many sources also count scalp psoriasis and nail psoriasis as distinct types, bringing the total to seven. Psoriatic arthritis is sometimes included as well, though it is technically a joint manifestation rather than a skin type.^{<a href="#ref4">[4]</a>}</p>

<h3 class="subsection-heading" id="faq-autoimmune-look">What does autoimmune psoriasis look like?</h3>

<p>All psoriasis is autoimmune. Its appearance depends on the type. Plaque psoriasis shows raised, scaly patches. Guttate psoriasis appears as small, scattered spots. Inverse psoriasis creates smooth, red patches in skin folds. Pustular psoriasis produces white blisters. On darker skin, "redness" may appear as purple, dark brown, or dusky tones instead.^{<a href="#ref10">[10]</a>}</p>

<h3 class="subsection-heading" id="faq-organ-linked">What organ is linked to psoriasis?</h3>

<p>Psoriasis is a systemic disease, not limited to the skin. It is associated with increased risk of cardiovascular disease, metabolic syndrome, inflammatory bowel disease, and depression. The cardiovascular system is the organ system most strongly linked to psoriasis-related mortality.^{<a href="#ref18">[18]</a>}</p>

<h3 class="subsection-heading" id="faq-biggest-trigger">What is the biggest trigger for psoriasis?</h3>

<p>Stress is consistently reported as the most common trigger for psoriasis flares, with studies showing that 40 to 80% of patients identify psychological stress as a factor in their disease.^{<a href="#ref43">[43]</a>} Other major triggers include infections (especially streptococcal), skin injury (Koebner phenomenon), certain medications, smoking, and heavy alcohol use.^{<a href="#ref16">[16]</a>} The role of psychological stress in inflammatory skin disease is explored in depth in our guide on <a href="https://harlanmd.com/blogs/smartlotion-blog/stress-and-eczema-how-the-two-are-connected">how stress triggers skin inflammation</a>.</p>

<h3 class="subsection-heading" id="faq-autoimmune-disease">Is psoriasis an autoimmune disease?</h3>

<p>Yes. Psoriasis is classified as an immune-mediated inflammatory disease. The immune system mistakenly attacks healthy skin cells, triggering rapid cell turnover and inflammation. This autoimmune process involves T cells, dendritic cells, and a cascade of inflammatory cytokines including TNF-alpha, IL-17, and IL-23.^{<a href="#ref17">[17]</a>} For a comparison of how autoimmune mechanisms differ between psoriasis and eczema, see our article on <a href="https://harlanmd.com/blogs/smartlotion-blog/is-atopic-dermatitis-an-autoimmune-disorder">whether atopic dermatitis is an autoimmune disorder</a>.</p>

<h3 class="subsection-heading" id="faq-eczema-vs-psoriasis">What is the difference between eczema and psoriasis?</h3>

<p>Eczema (atopic dermatitis) and psoriasis are both inflammatory skin conditions, but they differ in key ways. Eczema typically causes intense itching with dry, cracked skin and tends to appear in the creases of elbows and knees. Psoriasis produces thicker, well-defined plaques with silvery scale and favors the outer surfaces of elbows and knees.^{<a href="#ref44">[44]</a>} For a detailed comparison, see our guide on the <a href="https://harlanmd.com/blogs/smartlotion-blog/difference-between-psoriasis-and-eczema">difference between psoriasis and eczema</a>.</p>

<h2>References</h2>
<ol class="references">
          <li id="ref1">Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, on behalf of the Global Psoriasis Atlas. "National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study." <em>BMJ</em>. 2020. <a href="https://doi.org/10.1136/bmj.m1590" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref2">Uppala R, Tsoi LC, Harms PW, Wang B, Billi AC, Maverakis E, Kahlenberg JM, Ward NL, Gudjonsson JE. "'Autoinflammatory psoriasis'—genetics and biology of pustular psoriasis." <em>Cellular & Molecular Immunology</em>. 2021. <a href="https://doi.org/10.1038/s41423-020-0519-3" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref3">Singh R, Koppu S, Perche PO, Feldman SR. "The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications." <em>International Journal of Molecular Sciences</em>. 2021. <a href="https://doi.org/10.3390/ijms222312793" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref4">Dogra S, Mahajan R. "Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring." <em>Indian Dermatology Online Journal</em>. 2016. <a href="https://doi.org/10.4103/2229-5178.193906" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref5">Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, Kazemi LV, Kim MH, Trumble AE, Kotb M, et al. "Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis." <em>Journal of Clinical Investigation</em>. 1995. <a href="https://doi.org/10.1172/JCI118263" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref6">Merola JF, Li T, Li W-Q, Cho E, Qureshi AA. "Prevalence of psoriasis phenotypes among men and women in the USA." <em>Clinical and Experimental Dermatology</em>. 2016. <a href="https://doi.org/10.1111/ced.12805" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref7">Wilmer EN, Hatch RL. "Resistant 'Candidal Intertrigo': Could Inverse Psoriasis Be the True Culprit?" <em>Journal of the American Board of Family Medicine</em>. 2013;26(2):211-214. <a href="https://doi.org/10.3122/jabfm.2013.02.120210" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref8">Krueger J, Puig L, Thaçi D. "Treatment Options and Goals for Patients with Generalized Pustular Psoriasis." <em>American Journal of Clinical Dermatology</em>. 2022. <a href="https://doi.org/10.1007/s40257-021-00658-9" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref9">Sangphukieo A, Thongkumkoon P, Noisagul P, Lo Piccolo L, O'Brien TE, Chaowattanapanit S, et al. "Human Leukocyte Antigen Markers for Distinguishing Pustular Psoriasis and Adult-Onset Immunodeficiency with Pustular Reaction." <em>Genes</em>. 2024. <a href="https://doi.org/10.3390/genes15030278" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref10">Hermann AE, Nguyen DA, Wong CM, Scheufele CJ, Carletti M, Weis SE. "Presentations of Cutaneous Disease in Various Skin Pigmentations: Plaque Psoriasis." <em>HCA Healthcare Journal of Medicine</em>. 2022. <a href="https://doi.org/10.36518/2689-0216.1429" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref11">Alexis A, McMichael A, Soung J, et al. "Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial." <em>JAMA Dermatology</em>. 2025. <a href="https://doi.org/10.1001/jamadermatol.2025.1836" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref12">Coates LC, Helliwell PS. "Psoriatic arthritis: state of the art review." <em>Clinical Medicine (London)</em>. 2017. <a href="https://doi.org/10.7861/clinmedicine.17-1-65" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref13">Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Maradit Kremers H. "Incidence and Clinical Predictors of Psoriatic Arthritis in Patients With Psoriasis: A Population-Based Study." <em>Arthritis and Rheumatism</em>. 2009. <a href="https://doi.org/10.1002/art.24172" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref14">Costanza G, Doldo E, Ferlosio A, et al. "Expression and potential role of cellular retinol binding protein I in psoriasis." <em>Oncotarget</em>. 2018. <a href="https://doi.org/10.18632/oncotarget.26314" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref15">Hüffmeier U, Klima J, Hayatu MD. "Genetic underpinnings of the psoriatic spectrum." <em>Medizinische Genetik</em>. 2024. <a href="https://doi.org/10.1515/medgen-2023-2005" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref16">Roszkiewicz M, Dopytalska K, Szymańska E, Jakimiuk A, Walecka I. "Environmental risk factors and epigenetic alternations in psoriasis." <em>Annals of Agricultural and Environmental Medicine</em>. 2020. <a href="https://doi.org/10.26444/aaem/112107" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref17">Chhabra S, Dogra S, Sharma K, Raychaudhuri SK, Raychaudhuri SP. "Recent Update on Immunopathogenesis of Psoriasis." <em>Indian Journal of Dermatology</em>. 2022. <a href="https://doi.org/10.4103/ijd.ijd_569_22" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref18">Boehncke WH. "Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences." <em>Frontiers in Immunology</em>. 2018. <a href="https://doi.org/10.3389/fimmu.2018.00579" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref19">Shao S, Wang G, Maverakis E, Gudjonsson JE. "Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances." <em>Drugs</em>. 2020;80(6):525–534. <a href="https://doi.org/10.1007/s40265-020-01283-2" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref20">Verzì AE, Lacarrubba F, Musumeci ML, Caltabiano R, Micali G. "Line-Field Confocal Optical Coherence Tomography Imaging of Psoriasis With Histopathology Correlation." <em>Journal of Cutaneous Pathology</em>. 2024. <a href="https://doi.org/10.1111/cup.14734" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref21">Arnone M, Takahashi MDF, de Carvalho AVE, et al. "Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology." <em>Anais Brasileiros de Dermatologia</em>. 2019. <a href="https://doi.org/10.1590/abd1806-4841.2019940211" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref22">Karampinis E, Georgopoulou KE, Goudouras G, Lianou V, Kampra E, Roussaki Schulze AV, Zafiriou E. "Laser-Induced Koebner-Related Skin Reactions: A Clinical Overview." <em>Medicina (Kaunas)</em>. 2024. <a href="https://doi.org/10.3390/medicina60071177" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref23">Dhabale A, Nagpure S. "Types of Psoriasis and Their Effects on the Immune System." <em>Cureus</em>. 2022. <a href="https://doi.org/10.7759/cureus.29536" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref24">Pourani MR, Khajeamiri Y, Abdollahimajd F, Zargari O. "Psoriasis and Alopecia: Unveiling the Links." <em>Dermatology Practical & Conceptual</em>. 2025. <a href="https://doi.org/10.5826/dpc.1504a5283" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref25">Song HJ, Park CJ, Kim TY, et al. "The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE)." <em>Annals of Dermatology</em>. 2017. <a href="https://doi.org/10.5021/ad.2017.29.4.462" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref26">Johnston A, Gudjonsson JE, Sigmundsdottir H, Love TJ, Valdimarsson H. "Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells." <em>Clinical and Experimental Immunology</em>. 2004. <a href="https://doi.org/10.1111/j.1365-2249.2004.00600.x" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref27">Maruani A, Samimi M, Stembridge N, Abdel Hay R, Tavernier E, Hughes C, Le Cleach L. "Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis." <em>Cochrane Database of Systematic Reviews</em>. 2019. <a href="https://doi.org/10.1002/14651858.CD011541.pub2" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref28">Campos MA, Varela P, Baptista A, Moreira AI. "Inverse psoriasis treated with ustekinumab." <em>BMJ Case Reports</em>. 2016. <a href="https://doi.org/10.1136/bcr-2016-215019" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref29">Lebwohl MG, Medeiros RA, Mackey RH, Valdecantos WC, Brodovicz KG, Lertratanakul A, Strober B. "Palmoplantar Pustulosis has a Greater Disease Burden than Plaque Psoriasis: Real-World Evidence From the CorEvitas Psoriasis Registry." <em>Journal of Psoriasis and Psoriatic Arthritis</em>. 2022. <a href="https://doi.org/10.1177/24755303221146990" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref30">Gregoire ARF, DeRuyter BK, Stratman EJ. "Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis." <em>JAMA Dermatology</em>. 2021. <a href="https://doi.org/10.1001/jamadermatol.2020.4219" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref31">Megna M, Camela E, Ruggiero A, Battista T, Martora F, Cacciapuoti S, Potestio L. "Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?" <em>Clinical, Cosmetic and Investigational Dermatology</em>. 2023. <a href="https://doi.org/10.2147/CCID.S407812" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref32">Krishnamoorthy G, Kotecha A, Pimentel J. "Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy." <em>BMJ Case Reports</em>. 2019. <a href="https://doi.org/10.1136/bcr-2018-226959" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref33">Nieradko-Iwanicka B. "Nail psoriasis – what a rheumatologist should know about." <em>Reumatologia</em>. 2017. <a href="https://doi.org/10.5114/reum.2017.66687" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref34">Fratton Z, Giovannini I, Zabotti A, Errichetti E. "Skin and Nail Predictors of Psoriatic Arthritis Development: A Holistic Overview Integrating Epidemiological and Physiopathological Data." <em>Journal of Clinical Medicine</em>. 2024. <a href="https://doi.org/10.3390/jcm13226880" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref35">Trevisan F, Werner B, Pinheiro RL. "Nail clipping in onychomycosis and comparison with normal nails and ungual psoriasis." <em>Anais Brasileiros de Dermatologia</em>. 2019. <a href="https://doi.org/10.1590/abd1806-4841.20198301" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref36">Gantz HY, Yi RC, Ruley AJ, Mukenge MM, Swain EC, Kohrs AB, Nolde-Lopez BG, Vescovacci NM, Klionsky Y, Feldman SR. "Challenging the Dogma That Psoriasis Skin Lesions Occur Before Arthritis." <em>International Journal of Dermatology</em>. 2025. <a href="https://doi.org/10.1111/ijd.17862" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref37">Chang J, Litvinov IV, Ly C, Netchiporouk E, Tsoukas A, Thuraisingam T, Starr M, Powell M, Christodoulou G, Shamout Y. "Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage." <em>Journal of Cutaneous Medicine and Surgery</em>. 2022. <a href="https://doi.org/10.1177/12034754221128796" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref38">Zhu D, Li N, Yan X, Zheng M. "Self-management of psoriasis vulgaris treatment burden: A Review." <em>Medicine (Baltimore)</em>. 2023. <a href="https://doi.org/10.1097/MD.0000000000035392" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref39">Segaert S, Shear NH, Chiricozzi A, Thaçi D, Carrascosa JM, Young H, Descamps V. "Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy." <em>Dermatology and Therapy</em>. 2017. <a href="https://doi.org/10.1007/s13555-017-0196-z" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref40">Mason AR, Mason J, Cork M, Dooley G, Hancock H. "Topical treatments for chronic plaque psoriasis." <em>Cochrane Database of Systematic Reviews</em>. 2013. <a href="https://doi.org/10.1002/14651858.CD005028.pub3" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref41">Nguyen Van T, Hoang Van T, Pham Thi Minh P, et al. "Efficacy of Narrow-Band UVB Phototherapy versus PUVA Chemophototherapy for Psoriasis in Vietnamese Patients." <em>Open Access Macedonian Journal of Medical Sciences</em>. 2019. <a href="https://doi.org/10.3889/oamjms.2019.057" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref42">Sbidian E, Chaimani A, Garcia-Doval I, et al. "Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis." <em>Cochrane Database of Systematic Reviews</em>. 2022. <a href="https://doi.org/10.1002/14651858.CD011535.pub5" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref43">Yan D, Afifi L, Jeon C, Cordoro KM, Liao W. "A cross-sectional study of psoriasis triggers among different ethnoracial groups." <em>Journal of the American Academy of Dermatology</em>. 2017. <a href="https://doi.org/10.1016/j.jaad.2017.04.1109" target="_blank" rel="noopener">View Study</a></li>
          <li id="ref44">Gisondi P, Bellinato F, Girolomoni G. "Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks." <em>Journal of Clinical Medicine</em>. 2020. <a href="https://doi.org/10.3390/jcm9113594" target="_blank" rel="noopener">View Study</a></li>
        </ol>

<div class="author-bio"><div style="display: flex; align-items: flex-start; gap: 20px;"><div><h3>About the Author: Michael Anderson, Clinical Research Project Manager</h3><p>Michael bridges the gap between research labs and real patients. As our research project manager, he ensures groundbreaking studies translate into accessible treatments. A craft beer enthusiast and woodworking hobbyist, Michael approaches both his hobbies and research with the same attention to detail, although he admits that research protocols are significantly less forgiving than furniture joints.</p></div></div></div>

</div>

<script type="application/ld+json">
{
 "@context": "https://schema.org",
 "@type": "MedicalWebPage",
 "name": "Types of Psoriasis: Symptoms, Causes, and How to Tell Them Apart",
 "image": "[Leave - Replaced By User]",
 "headline": "Types of Psoriasis: Symptoms, Causes, and How to Tell Them Apart",
 "description": "Learn about every type of psoriasis, from plaque to erythrodermic. Spot the differences, understand triggers, and find the right treatment approach.",
 "url": "https://harlanmd.com/blogs/smartlotion-blog/types-of-psoriasis",
 "keywords": "types of psoriasis, psoriasis types, plaque psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, erythrodermic psoriasis, nail psoriasis, scalp psoriasis, psoriatic arthritis",
 "datePublished": "2025-01-15",
 "dateModified": "2025-01-15",
 "author": {
 "@type": "Person",
 "name": "Michael Anderson",
 "jobTitle": "Clinical Research Project Manager",
 "worksFor": {"@type": "Organization", "name": "HarlanMD"}
 },
 "publisher": {
 "@type": "Organization",
 "name": "HarlanMD",
 "logo": {"@type": "ImageObject", "url": "https://cdn.shopify.com/s/files/1/0529/7170/0417/files/sl-logo.png?v=1653151227"}
 },
 "mainEntityOfPage": {"@type": "WebPage", "@id": "https://harlanmd.com/blogs/smartlotion-blog/types-of-psoriasis"},
 "medicalAudience": {
 "@type": "MedicalAudience",
 "audienceType": "Patient",
 "healthCondition": {"@type": "MedicalCondition", "name": "Psoriasis", "alternateName": "Psoriasis Types"}
 },
 "about": {
 "@type": "MedicalCondition",
 "name": "Psoriasis",
 "alternateName": "Psoriasis Types",
 "symptoms": ["Raised red or discolored skin patches with silvery scales", "Small drop-shaped spots", "Smooth red patches in skin folds", "Pus-filled blisters on skin", "Widespread skin redness and shedding", "Nail pitting and discoloration", "Joint pain and stiffness"],
 "possibleTreatment": [
 {"@type": "MedicalTherapy", "name": "Topical corticosteroids"},
 {"@type": "MedicalTherapy", "name": "Phototherapy"},
 {"@type": "MedicalTherapy", "name": "Biologic therapies (TNF-alpha, IL-17, IL-23 inhibitors)"},
 {"@type": "MedicalTherapy", "name": "Systemic immunosuppressants"},
 {"@type": "MedicalTherapy", "name": "Topical calcineurin inhibitors"}
 ]
 },
 "articleBody": "By Michael Anderson, Clinical Research Project Manager • Updated: January 15, 2025 Not all psoriasis looks the same. One person develops thick, scaly patches on their elbows. Another wakes up covered in tiny, drop-shaped spots after a sore throat. A third notices smooth, red skin hidden in their armpits. Psoriasis affects roughly 2 to 3% of the global population, yet many people go years without knowing which type they have. [1] If you have tried treatments that barely helped, the problem may not be the treatment itself. You might be managing the wrong type. Each form of psoriasis behaves differently, responds to different triggers, and often requires a different approach. [2] This guide walks you through every major type of psoriasis, explains why each one looks and acts the way it does, and helps you match your symptoms to the right category. For a broader look at psoriasis as a condition, see our complete psoriasis overview . Recent research has mapped the distinct immune pathways behind each psoriasis type, revealing why a treatment that clears plaque psoriasis may do nothing for pustular disease. [3] Understanding your type is the first step toward real relief. Key Takeaways"
}
</script>

<script type="application/ld+json">
{
 "@context": "https://schema.org",
 "@type": "FAQPage",
 "mainEntity": [
 {
 "@type": "Question",
 "name": "What are the 7 types of psoriasis?",
 "acceptedAnswer": {
 "@type": "Answer",
 "text": "The major types of psoriasis include plaque psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, and erythrodermic psoriasis. Many sources also count scalp psoriasis and nail psoriasis as distinct types, bringing the total to seven. Psoriatic arthritis is sometimes included as well, though it is technically a joint manifestation rather than a skin type."
 }
 },
 {
 "@type": "Question",
 "name": "What does autoimmune psoriasis look like?",
 "acceptedAnswer": {
 "@type": "Answer",
 "text": "All psoriasis is autoimmune. Its appearance depends on the type. Plaque psoriasis shows raised, scaly patches. Guttate psoriasis appears as small, scattered spots. Inverse psoriasis creates smooth, red patches in skin folds. Pustular psoriasis produces white blisters. On darker skin, redness may appear as purple, dark brown, or dusky tones instead."
 }
 },
 {
 "@type": "Question",
 "name": "What organ is linked to psoriasis?",
 "acceptedAnswer": {
 "@type": "Answer",
 "text": "Psoriasis is a systemic disease, not limited to the skin. It is associated with increased risk of cardiovascular disease, metabolic syndrome, inflammatory bowel disease, and depression. The cardiovascular system is the organ system most strongly linked to psoriasis-related mortality."
 }
 },
 {
 "@type": "Question",
 "name": "What is the biggest trigger for psoriasis?",
 "acceptedAnswer": {
 "@type": "Answer",
 "text": "Stress is consistently reported as the most common trigger for psoriasis flares, with studies showing that 40 to 80% of patients identify psychological stress as a factor in their disease. Other major triggers include infections (especially streptococcal), skin injury, certain medications, smoking, and heavy alcohol use."
 }
 },
 {
 "@type": "Question",
 "name": "Is psoriasis an autoimmune disease?",
 "acceptedAnswer": {
 "@type": "Answer",
 "text": "Yes. Psoriasis is classified as an immune-mediated inflammatory disease. The immune system mistakenly attacks healthy skin cells, triggering rapid cell turnover and inflammation. This autoimmune process involves T cells, dendritic cells, and a cascade of inflammatory cytokines including TNF-alpha, IL-17, and IL-23."
 }
 },
 {
 "@type": "Question",
 "name": "What is the difference between eczema and psoriasis?",
 "acceptedAnswer": {
 "@type": "Answer",
 "text": "Eczema (atopic dermatitis) and psoriasis are both inflammatory skin conditions, but they differ in key ways. Eczema typically causes intense itching with dry, cracked skin and tends to appear in the creases of elbows and knees. Psoriasis produces thicker, well-defined plaques with silvery scale and favors the outer surfaces of elbows and knees."
 }
 }
 ]
}
</script>